Cancer (Oncology)

The inventive step: antibody-drug conjugates

Monday 8 April 2013

Interviewee/Contributer: John Lambert

Organisation: ImmunoGen Inc

Full text available to subscribers only. Click here for information on subscribing to MedNous.

10-year oncology review: innovation accelerates

Sunday 7 April 2013

Interviewee/Contributer: Bruno Pagliara

Organisation: On-kòs Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Approvals of cancer drugs set record in 2012

Sunday 10 February 2013

Interviewee/Contributer: Bruno Pagliara

Organisation: On-kòs Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Do oncolytic viruses have a future as combination therapies?

Saturday 9 February 2013

Interviewee/Contributer: Steven Powell

Organisation: Virttu Biologics Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Survey of prostate cancer drugs

Friday 12 October 2012

Interviewee/Contributer: Bruno Pagliara

Organisation: On-kos Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

An analysis of accelerated approval for cancer drugs

Wednesday 18 July 2012

Interviewee/Contributer: Bruno Pagliara

Organisation: On-Kos Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Antibodies and ADCs lead cancer pipeline

Saturday 19 May 2012

Interviewee/Contributer: Bruno Pagliara

Organisation: On-Kos Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

New study puts breast cancer into 10 subgroups

Friday 18 May 2012

Interviewee/Contributer: Christina Curtis

Organisation: Keck School of Medicine, University of Southern California

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Oncology review for 2011

Sunday 19 February 2012

Interviewee/Contributer: Bruno Pagliara

Organisation: On-Kos Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How developers approach antibody drug conjugates

Saturday 12 November 2011

Interviewee/Contributer: Bruno Pagliara

Organisation: On-kòs Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content